Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral clonidine for treatment of diabetic neuropathy
IRCT20211106052983N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clonidine in diabetic neuropathy, sponsored by Yasouj University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
clonidine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20211106052983N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211106052983N1.